Medpharmics, LLC

Phoenix, Arizona 85379

0 studies enrolling now · 15 studies all time

What they study most

COVID-19, Chlamydia Trachomatis Infection, Clostridium Difficile Infection, Cytomegalovirus Infection, Gastro-Intestinal Tolerance, Hot Flashes, Human Papillomavirus, Infant Development, Lower Respiratory Tract Disease, Maternal Immunization, Migraine, Pneumococcal Disease

Studies at this site

• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters — Completed
• A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age — Completed
• To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older — Completed
• A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause — Completed
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening — Completed
• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Formula Tolerance of Term Infants — Completed
• A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN — Completed
• Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults — Completed
• Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas — Completed
• Phase 2B/3 Double-blinded Placebo-controlled — Completed